Skip to main content
Top
Published in: Rheumatology International 12/2007

01-10-2007 | Original Article

Pro-inflammatory cellular immune response in Behçet’s disease

Authors: Ayla Kulaber, Ilknur Tugal-Tutkun, Sibel P. Yentür, Gülşen Akman-Demir, Fumio Kaneko, Ahmet Gül, Güher Saruhan-Direskeneli

Published in: Rheumatology International | Issue 12/2007

Login to get access

Abstract

Several proteins are investigated as candidate auto-antigens in the pathogenesis of Behçet’s disease (BD). This study aimed to screen the cellular responses to auto-antigen (αB-crystallin, αBC), and microorganism (Streptococcus sangius KTH-1 BES-1 protein) derived peptides as well as to isopentenyl pyrophosphate (IPP). Peripheral blood mononuclear cells (PBMC) from 22 BD patients and 22 healthy controls (HC) were stimulated in vitro with αBC, BES-1 peptides, IPP and PPD and induced proliferation as well as the secreted interleukin (IL)-12 and interferon (IFN)-γ production levels were measured. We did not observe any significant difference in cellular proliferation between BD patients and HC. Induction of IL-12 secretion with αBC was stronger in BD patients (P = 0.04) and in the disease subgroup with uveitis (P = 0.027) compared the HC. When responses to PPD were compared, proliferation of PMBC was lower (P = 0.03), whereas IL-12 secretion was higher in BD (P = 0.04) as well as in patients under colchicum treatment (P = 0.04) and with vascular involvement (P = 0.006) compared to HC. BES-1373–385 peptide induced also higher IL-12 productions by PBMC of BD patients (P = 0.017) and of patients with uveitis (P = 0.013). Finally, IPP stimulated higher IL-12 secretions from PBMC in BD patients (P = 0.035) and in patients with (P = 0.02) or without (P = 0.017) uveitis or arthritis (P = 0.04), under colchicum treatment (P = 0.01) or not receiving any immunosuppressive treatment (P = 0.007) compared to HC. These results suggest a more prominent pro-inflammatory cytokine secretion from PBMC in BD patients compared to HC in response to various antigens including αBC protein, BES-1373–385, IPP and PPD.
Literature
1.
go back to reference Gul A (2001) Behcet’s disease: an update on the pathogenesis. Clin Exp Rheumatol 19:S6–S12PubMed Gul A (2001) Behcet’s disease: an update on the pathogenesis. Clin Exp Rheumatol 19:S6–S12PubMed
2.
go back to reference Direskeneli H (2001) Behcet’s disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 60:996–1002PubMedCrossRef Direskeneli H (2001) Behcet’s disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 60:996–1002PubMedCrossRef
3.
go back to reference Yamamoto J, Minami M, Inaba G, Masuda K, Mochizuki M (1993) Cellular autoimmunity to retinal specific antigens in patients with Behcet’s disease. Br J Ophthalmol 77:584–589PubMed Yamamoto J, Minami M, Inaba G, Masuda K, Mochizuki M (1993) Cellular autoimmunity to retinal specific antigens in patients with Behcet’s disease. Br J Ophthalmol 77:584–589PubMed
4.
go back to reference Mahesh SP, Li Z, Buggage R, Mor F, Cohen IR, Chew EY, Nussenblatt RB (2005) Alpha tropomyosin as a self-antigen in patients with Behcet’s disease. Clin Exp Immunol 140:368–375PubMedCrossRef Mahesh SP, Li Z, Buggage R, Mor F, Cohen IR, Chew EY, Nussenblatt RB (2005) Alpha tropomyosin as a self-antigen in patients with Behcet’s disease. Clin Exp Immunol 140:368–375PubMedCrossRef
5.
go back to reference Direskeneli H, Saruhan-Direskeneli G (2003) The role of heat shock proteins in Behcet’s disease. Clin Exp Rheumatol 21:S44–S48PubMed Direskeneli H, Saruhan-Direskeneli G (2003) The role of heat shock proteins in Behcet’s disease. Clin Exp Rheumatol 21:S44–S48PubMed
6.
go back to reference Tasci B, Direskeneli H, Serdaroglu P, Akman-Demir G, Eraksoy M, Saruhan-Direskeneli G (1998) Humoral immune response to mycobacterial heat shock protein (hsp) 65 in the cerebrospinal fluid of neuro-Behcet patients. Clin Exp Immunol 113:100–104PubMedCrossRef Tasci B, Direskeneli H, Serdaroglu P, Akman-Demir G, Eraksoy M, Saruhan-Direskeneli G (1998) Humoral immune response to mycobacterial heat shock protein (hsp) 65 in the cerebrospinal fluid of neuro-Behcet patients. Clin Exp Immunol 113:100–104PubMedCrossRef
7.
go back to reference Bhat S, Nagineni C (1989) Alpha B subunit of lens-specific protein α-crystallin is present in other ocular and non-ocular tissues. Biochem Biophys Res Commun 158:319–325PubMedCrossRef Bhat S, Nagineni C (1989) Alpha B subunit of lens-specific protein α-crystallin is present in other ocular and non-ocular tissues. Biochem Biophys Res Commun 158:319–325PubMedCrossRef
8.
go back to reference van Noort J, van Sechel A, Bajramovic J, el Ouagmiri M, Polman C, Lassmann H, Ravid R (1995) The small heat-shock protein αB-crystallin as candidate autoantigen in multiple sclerosis. Nature 375:798–801PubMedCrossRef van Noort J, van Sechel A, Bajramovic J, el Ouagmiri M, Polman C, Lassmann H, Ravid R (1995) The small heat-shock protein αB-crystallin as candidate autoantigen in multiple sclerosis. Nature 375:798–801PubMedCrossRef
9.
go back to reference Celet B, Akman-Demir G, Serdaroglu P, Yentur SP, Tasci B, van Noort JM, Eraksoy M, Saruhan-Direskeneli G (2000) Anti-αB-crystallin immunoreactivity in inflammatory nervous system diseases. J Neurol 247:935–939PubMedCrossRef Celet B, Akman-Demir G, Serdaroglu P, Yentur SP, Tasci B, van Noort JM, Eraksoy M, Saruhan-Direskeneli G (2000) Anti-αB-crystallin immunoreactivity in inflammatory nervous system diseases. J Neurol 247:935–939PubMedCrossRef
10.
go back to reference Lehner T (1997) The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behcet’s disease. Int Rev Immunol 14:21–32PubMed Lehner T (1997) The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behcet’s disease. Int Rev Immunol 14:21–32PubMed
11.
go back to reference Yoshikawa K, Kotake S, Kubota T, Kimura K, Isogai E, Fuji N (1998) Cloning and sequencing of BES-1 gene encoding the immunogenic antigen of Streptococcus sanguis KTH-1 isolated from the patients with Behcet’s disease. Zentralbl Bakteriol 287:449–460PubMed Yoshikawa K, Kotake S, Kubota T, Kimura K, Isogai E, Fuji N (1998) Cloning and sequencing of BES-1 gene encoding the immunogenic antigen of Streptococcus sanguis KTH-1 isolated from the patients with Behcet’s disease. Zentralbl Bakteriol 287:449–460PubMed
12.
go back to reference Suzuki Y, Hoshi K, Matsuda T, Mizushima Y (1992) Increased peripheral blood γδ + T cells and natural killer cells in Behcet’s disease. J Rheumatol 19:588–592PubMed Suzuki Y, Hoshi K, Matsuda T, Mizushima Y (1992) Increased peripheral blood γδ + T cells and natural killer cells in Behcet’s disease. J Rheumatol 19:588–592PubMed
13.
go back to reference Fortune F, Walker J, Lehner T (1990) The expression of γδ T cell receptor and the prevalence of primed, activated and IgA-bound T cells in Behcet’s syndrome. Clin Exp Immunol 82:326–332PubMedCrossRef Fortune F, Walker J, Lehner T (1990) The expression of γδ T cell receptor and the prevalence of primed, activated and IgA-bound T cells in Behcet’s syndrome. Clin Exp Immunol 82:326–332PubMedCrossRef
14.
go back to reference Yamashita N, Kaneoka H, Kaneko S, Takeno M, Oneda K, Koizumi H, Kogure M, Inaba G, Sakane T (1997) Role of γδ T lymphocytes in the development of Behcet’s disease. Clin Exp Immunol 107:241–247PubMedCrossRef Yamashita N, Kaneoka H, Kaneko S, Takeno M, Oneda K, Koizumi H, Kogure M, Inaba G, Sakane T (1997) Role of γδ T lymphocytes in the development of Behcet’s disease. Clin Exp Immunol 107:241–247PubMedCrossRef
15.
go back to reference Bank I, Duvdevani M, Livneh A (2003) Expansion of γδ T-cells in Behcet’s disease: role of disease activity and microbial flora in oral ulcers. J Lab Clin Med, The (LAB) 141:33–40 Bank I, Duvdevani M, Livneh A (2003) Expansion of γδ T-cells in Behcet’s disease: role of disease activity and microbial flora in oral ulcers. J Lab Clin Med, The (LAB) 141:33–40
16.
go back to reference Mochizuki N, Suzuki N, Takeno M, Nagafuchi H, Harada T, Kaneoka H, Yamashita N, Hirayama K, Nakajima T, Mizushima Y (1994) Fine antigen specificity of human γδ T cell lines established by repetitive stimulation with a serotype (KTH-1) of a gram-positive bacterium, Str Sanguis. Eur J Immunol 24:1536–1543PubMedCrossRef Mochizuki N, Suzuki N, Takeno M, Nagafuchi H, Harada T, Kaneoka H, Yamashita N, Hirayama K, Nakajima T, Mizushima Y (1994) Fine antigen specificity of human γδ T cell lines established by repetitive stimulation with a serotype (KTH-1) of a gram-positive bacterium, Str Sanguis. Eur J Immunol 24:1536–1543PubMedCrossRef
17.
go back to reference Lafont V, Liautard J, Sable-Teychene M, Sainte-Marie Y, Favero J (2001) Isopentenyl pyrophosphate, a mycobacterial non-peptidic antigen, triggers delayed and highly sustained signaling in human γδ T lymphocytes without inducing down-modulation of T cell antigen receptor. J Biol Chem 276:15961–15967PubMedCrossRef Lafont V, Liautard J, Sable-Teychene M, Sainte-Marie Y, Favero J (2001) Isopentenyl pyrophosphate, a mycobacterial non-peptidic antigen, triggers delayed and highly sustained signaling in human γδ T lymphocytes without inducing down-modulation of T cell antigen receptor. J Biol Chem 276:15961–15967PubMedCrossRef
18.
go back to reference Verjans GM, van Hagen PM, van der Kooi A, Osterhaus AD, Baarsma GS (2002) Vγ9Vδ2 T cells recovered from eyes of patients with Behcet’s disease recognize non-peptide prenyl pyrophosphate antigens. J Neuroimmunol 130:46–54PubMedCrossRef Verjans GM, van Hagen PM, van der Kooi A, Osterhaus AD, Baarsma GS (2002) Vγ9Vδ2 T cells recovered from eyes of patients with Behcet’s disease recognize non-peptide prenyl pyrophosphate antigens. J Neuroimmunol 130:46–54PubMedCrossRef
19.
go back to reference International Study Group for Behçet’s, Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080 International Study Group for Behçet’s, Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080
20.
go back to reference Moss W, Ryon J, Monze M, Cutts F, Quinn T, Griffin D. (2002) Suppression of human immunodeficiency virus replication during acute measles. J Infect Dis 185:1035–1042PubMedCrossRef Moss W, Ryon J, Monze M, Cutts F, Quinn T, Griffin D. (2002) Suppression of human immunodeficiency virus replication during acute measles. J Infect Dis 185:1035–1042PubMedCrossRef
21.
go back to reference van Sechel AC, van Stipdonk MJB, Persoon-Deen C, Geutskens SB, van Noort JM (1999) EBV-induced expression and HLA-DR-restricted presentation by human B cells of αB-crystallin, a candidate autoantigen in multiple slerosis. J Immunol 162:129–135PubMed van Sechel AC, van Stipdonk MJB, Persoon-Deen C, Geutskens SB, van Noort JM (1999) EBV-induced expression and HLA-DR-restricted presentation by human B cells of αB-crystallin, a candidate autoantigen in multiple slerosis. J Immunol 162:129–135PubMed
22.
go back to reference Kaneko F, Oyama N, Nishibu A (1997) Streptococcal infection in the pathogenesis of Behcet’s disease and clinical effects of minocycline on the disease symptoms. Yonsei Med J 38:444–454PubMed Kaneko F, Oyama N, Nishibu A (1997) Streptococcal infection in the pathogenesis of Behcet’s disease and clinical effects of minocycline on the disease symptoms. Yonsei Med J 38:444–454PubMed
23.
go back to reference Hirohata S, Oka H, Mizushima Y (1992) Streptococcal-related antigens stimulate production of IL6 and interferon-γ by T cells from patients with Behcet’s disease. Cell Immunol 140:410–419PubMedCrossRef Hirohata S, Oka H, Mizushima Y (1992) Streptococcal-related antigens stimulate production of IL6 and interferon-γ by T cells from patients with Behcet’s disease. Cell Immunol 140:410–419PubMedCrossRef
24.
go back to reference Nishida T, Hirayama K, Nakamura S, Ohno S (1998) Proliferative response of CD8+ γδ + T cells to Streptococcus sanguis in patients with Behcet’s disease. Ocul Immunol Inflamm 6:139–144PubMedCrossRef Nishida T, Hirayama K, Nakamura S, Ohno S (1998) Proliferative response of CD8+ γδ + T cells to Streptococcus sanguis in patients with Behcet’s disease. Ocul Immunol Inflamm 6:139–144PubMedCrossRef
25.
go back to reference de Smet M, Dayan M (2000) Prospective determination of T-cell responses to S-antigen in Behcet’s disease patients and controls. Invest Ophthalmol Vis Sci 41:3480–3484PubMed de Smet M, Dayan M (2000) Prospective determination of T-cell responses to S-antigen in Behcet’s disease patients and controls. Invest Ophthalmol Vis Sci 41:3480–3484PubMed
Metadata
Title
Pro-inflammatory cellular immune response in Behçet’s disease
Authors
Ayla Kulaber
Ilknur Tugal-Tutkun
Sibel P. Yentür
Gülşen Akman-Demir
Fumio Kaneko
Ahmet Gül
Güher Saruhan-Direskeneli
Publication date
01-10-2007
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 12/2007
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-007-0367-9

Other articles of this Issue 12/2007

Rheumatology International 12/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine